Small Molecules
16 January 2013
FDA ACCEPTS SUPPLEMENTAL NEW DRUG APPLICATION FOR TARCEVA (ERLOTINIB) TABLETS FOR GENETICALLY DISTINCT FORM OF ADVANCED LUNG CANCER11 January 2013
ZYTIGA Approved in the EU for Use in the Treatment of Metastatic Castration-Resistant Prostate Cancer Before Chemotherapy11 January 2013
Merck Provides Update on Next Steps for TREDAPTIVE (extended-release niacin/laropiprant)11 January 2013
Daiichi Sankyo and ArQule Announce Top-Line Results of Phase 2 Trial with Tivantinib in Colorectal Cancer11 January 2013
FDA Advisory Committee Recommends Approval of Canagliflozin for Treatment of Adults with Type 2 Diabetes10 January 2013
InSite Vision Completes Phase 3 Clinical Study of BromSite for the Reduction of Pain and Inflammation After Cataract Surgery10 January 2013
Ultragenyx Announces In-Licensing of Clinical-Stage Product Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorders9 January 2013
Cell Therapeutics Begins Enrollment in Phase 3 PERSIST-1 Trial of Pacritinib for the Treatment of Myelofibrosis9 January 2013
The Medicines Company Announces Positive Results in a Phase 3 Trial of Cangrelor in the Treatment of Patients Undergoing PCI9 January 2013
Theravance and Alfa Wassermann Announce Initiation of Phase 2 Study With Velusetrag for Gastroparesis8 January 2013
Edison Pharmaceuticals Announces Initiation of EPI-743 Phase 2B Friedreich’s Ataxia Clinical Trial8 January 2013
Addex Announces Positive Data with ADX71441 in a Pre-Clinical Transgenic Model of Charcot-Marie-Tooth 1A Disease8 January 2013
Esperion Announces Positive Topline Results from a Phase 2 Clinical Trial of ETC-1002 in Patients with Type 2 Diabetes8 January 2013
ChemoCentryx Advances a New Generation CCR9 Inhibitor, CCX507, Into Clinical Development8 January 2013
First Patient Enrolled in Hanmi’s Phase 1b/IIa Clinical Trial in Korea, using KX01/Paclitaxel Combination8 January 2013
Telormedix granted IND for Phase II in bladder cancerNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports